ライフサイエンスコーパス: malondialdehyde

1 oxidative stress (3-fold reduction in tissue malondialdehyde).

2 d peroxidation biomarkers 8-isoprostanes and malondialdehyde.

3 nals, and lipid peroxidation products, e.g., malondialdehyde.

4 ication of dG residues with base propenal or malondialdehyde.

5 cies (RCS) acrolein, hydroxyl-2-nonenal, and malondialdehyde.

6 rom exposure of DNA to base propenals and to malondialdehyde.

7 odel for the exocylic M 1dG adduct formed by malondialdehyde.

8 ic replacement of the trimethylene tether by malondialdehyde.

9 uld be found in incubations of collagen with malondialdehyde.

10 wing a 4-day incubation of albumin with 8 mm malondialdehyde.

11 measurements of myeloperoxidase activity and malondialdehyde.

12 e activity, tumor necrosis factor-alpha, and malondialdehyde.

13 rescence parameters and their high levels of malondialdehyde.

14 cant suppression of oxidative stress (plasma malondialdehyde, 22%; 8-isoprostane-F(2alpha), 12%; P <

15 ction of IL-12 (-25% versus -4% versus -2%), malondialdehyde (-27% versus +5% versus +26%), and NT-pr

16 inary 8-iso-prostaglandin F(2alpha), urinary malondialdehyde + 4-hydroxyalkenals, and serum oxygen-ra

17 Neither vitamin had an effect on urinary malondialdehyde + 4-hydroxyalkenals.

18 cally relevant reactive aldehydes (acrolein, malondialdehyde, 4-hydroxy-2-nonenal, and 4-oxo-2-nonena

19 There was a significant increase of malondialdehyde, 4-hydroxynonenal adducts, 3-nitrotyrosi

20 Increased protein carbonyls, malondialdehyde, 4-hydroxynonenal-protein adducts, eleva

21 Malondialdehyde/4-hydroxyalkenals concentrations (mean +

22 region) showed the highest protection toward malondialdehyde (83.3% reduction).

23 ed to a decreased intestinal accumulation of malondialdehyde, a biomarker of lipid peroxidation.

24 Malondialdehyde, a genotoxic byproduct of lipid peroxida

25 nt brain regions removed for assay of VC and malondialdehyde, a marker of lipid peroxidation.

26 GPX was also positively associated with malondialdehyde, a marker of oxidative damage.

27 Levels of malondialdehyde, a marker of ROS generation and oxidant

28 ell as accumulation of hydrogen peroxide and malondialdehyde, a product of lipid peroxidation.

29 xidized GSH ratios and analyses of levels of malondialdehyde, a product of the free radical damage of

30 Malondialdehyde, acetaldehyde, acrolein, and 4-hydroxyno

31 nol-fed ALDH2(-/-) mice had higher levels of malondialdehyde-acetaldehyde (MAA) adduct and greater he

32 bound immunodominant OSE adducts termed MAA (malondialdehyde-acetaldehyde-adducts), which are found o

33 ldehyde-bovine serum albumin (f-Alb) or 125I-malondialdehyde-acetaldehyde-bovine serum albumin (MAA-A

34 with the SR-binding ligands oxidized LDL and malondialdehyde-acetaldehyde-modified LDL.

35 as well as the higher hydrogen peroxide and malondialdehyde additionally contribute to premature sen

36 The conclusion from this work is that malondialdehyde adducts in the transcribed strand of exp

37 serum albumin also revealed two acid-labile malondialdehyde adducts of histidine in significant quan

38 and ROS generation, reduced the formation of malondialdehyde adducts, maintained a normal distributio

39 , glutathione), markers of oxidative stress (malondialdehyde, ADP-ribose) and nicotinic coenzymes (NA

40 Malondialdehyde (an index of lipid peroxidation) was mea

41 Malondialdehyde, an indicator of oxidative stress indica

42 sed, whereas the lipid peroxidation products malondialdehyde and 4-hydroxy-2(E)-nonenal were increase

43 ith NAC reduced myocardial concentrations of malondialdehyde and 4-hydroxy-2(E)-nonenal, markers of o

44 duced an elevation in the hydroxyl radicals, malondialdehyde and 4-hydroxy-2,3-nonenal (HNE), causing

45 tive stress, as indicated by the decrease of malondialdehyde and 4-hydroxynonenal content in BAL of R

46 Malondialdehyde and 4-hydroxynonenal were measured in br

47 rance of lipid peroxidation products such as malondialdehyde and 4-hydroxynonenal-2-nonenal.

48 c inflammation and oxidative stress (urinary malondialdehyde and 8-hydroxy-2'-deoxyguanosine, plasma

49 ression and serum levels of Klotho, improved malondialdehyde and 8-hydroxy-deoxy guanosine levels, an

50 Malondialdehyde and 8-oxodG were significantly associate

51 xidative stress, evidenced by an increase in malondialdehyde and a decrease in reduced glutathione in

52 cant rise in the content of ATP-catabolites, malondialdehyde and ADP-ribose.

53 The biological aldehydes, malondialdehyde and base propenal, react with DNA to for

54 els of two biomarkers of lipid peroxidation, malondialdehyde and F(2)-isoprostanes, in 298 healthy ad

55 PB and Aroclor 1254 significantly enhanced malondialdehyde and H2O2 generation and NADPH oxidation

56 HDL-bound malondialdehyde and HDL-induced NO production by EC were

57 1 (VCAM-1), secretory phospholipase A2, and malondialdehyde and hydroxyalkenals (MDA+HAE) in elderly

58 munohistochemistry to detect the presence of malondialdehyde and hydroxynonenal adducts.

59 lected and analyzed for histology, levels of malondialdehyde and liver enzymes, gene expression, and

60 ry occluded rats demonstrated high levels of malondialdehyde and low levels of reduced glutathione an

61 dation by-products as reflected by increased malondialdehyde and oxidized albumin.

62 AD decreased malondialdehyde and oxidized LDL at 7 d (35% and 11%, re

63 barbituric acid reactive substances (TBARS), malondialdehyde and phytosterol oxidation products (POPs

64 concentration of oxidative stress byproduct malondialdehyde and pro-inflammatory cytokine tumor necr

65 d nitrotyrosine and quantitative analysis of malondialdehyde and protein carbonyl in the liver.

66 After 12 weeks, RBBO significantly decreased malondialdehyde and restored superoxide dismutase, catal

67 P < 0.05) with the changes in CIELAB colour, malondialdehyde and sensory scoring than with the change

68 n of DNA with the lipid peroxidation product malondialdehyde and the DNA peroxidation product base pr

69 d glycoprotein were determined in serum, and malondialdehyde and total glutathione content were deter

70 Malondialdehyde and total glutathione content were measu

71 ions of protein (3-nitrotyrosine) and lipid (malondialdehyde) and increase GSH content both in bleomy

72 peroxidase was incubated with glycine, H2O2, malondialdehyde, and a lysine analog in PBS at a physiol

73 eta, protein carbonyl, higher nitrotyrosine, malondialdehyde, and Fas/Fas ligand than non-CAD (P<0.05

74 tic peptide), TNF-alpha, IL-6, IL-12, IL-17, malondialdehyde, and fetuin-a.

75 ts of oxidative stress: 4-hydroxy-2-nonenal, malondialdehyde, and glycolaldehyde.

76 electrophile signals such as phytoprostanes, malondialdehyde, and hexenal in plastids.

77 associated with higher airway 8-isoprostane, malondialdehyde, and IL-13 concentrations.

78 locked basal and maximal formation of CD and malondialdehyde, and lengthened the lag times of LDL, sd

79 tric oxide and exhaled breath condensate pH, malondialdehyde, and nitrite), and systemic inflammation

80 peroxidation products: hydroxy fatty acids, malondialdehyde, and phytoprostanes.

81 e synthase, 3-nitrotyrosine protein adducts, malondialdehyde, and protein carbonyls were also higher

82 ) as evidenced by the increased formation of malondialdehyde, and reduced antioxidant enzymes includi

83 esterol levels, LDL oxidizability (lag time, malondialdehyde, and relative electrophoretic mobility)

84 tive stress markers, including antibodies to malondialdehyde (anti-MDA) protein adducts and to 4-hydr

85 om each species of milk was determined using malondialdehyde as an oxidation product marker.

86 otoxic aldehydes including methylglyoxal and malondialdehyde as substrates and the reduced form of ni

87 smin activity, ceruloplasmin protein, plasma malondialdehyde, benzylamine oxidase activity, erythrocy

88 II by HDL(NYHA-IIIb), and a higher amount of malondialdehyde bound to HDL(NYHA-IIIb) compared with HD

89 inflammatory cell infiltration, lung tissue malondialdehyde, bronchoalveolar lavage fluid protein co

90 d production of the oxidative stress marker, malondialdehyde by ~80%.

91 th a corresponding increase in the levels of malondialdehyde by-product (fourfold).

92 F(2)-isoprostanes, malondialdehyde, C-reactive protein, serum vitamin C, ca

93 oduced non-significantly different levels of malondialdehyde compared to the blank containing no ferr

94 sed amount of the lipid peroxidation product malondialdehyde compared to the wild type, suggesting th

95 g) in the meat of the SBs compared with the malondialdehyde concentration (1.79 +/- 0.17 micromol/25

96 There was a 71% reduction in the malondialdehyde concentration (mean +/- SD: 0.52 +/- 0.0

97 The plasma malondialdehyde concentration increased significantly in

98 groups, although, paradoxically, the plasma malondialdehyde concentration was significantly higher a

99 itro antioxidant activity was able to reduce malondialdehyde concentration.

100 83.2 +/- 2470.1 ng/mL, P = 0.03), and plasma malondialdehyde concentrations (-0.5 +/- 1.6 vs. +0.3 +/

101 fidence interval: -53.5, -15.7), and urinary malondialdehyde concentrations (-25.3%; 95% confidence i

102 Urinary malondialdehyde concentrations (micromol/g creatinine) d

103 production of malondialdehyde in burgers and malondialdehyde concentrations in plasma and urine after

104 urger meat before cooking was a reduction in malondialdehyde concentrations in the meat, plasma, and

105 erol concentrations (all P < 0.01) and lower malondialdehyde concentrations, which persisted after ad

106 relation to airway IL-13, 8-isoprostane, and malondialdehyde concentrations.

107 r meat and its effects on plasma and urinary malondialdehyde concentrations.

108 zed monoclonal autoantibody that reacts with malondialdehyde-conjugated LDL, was labeled with a NIRF

109 tformin also attenuated oxidative stress and malondialdehyde-containing protein levels, with correspo

110 Significant increase of malondialdehyde content and decrease of neutral red rete

111 Also, they showed lesser malondialdehyde content and electrolyte leakage compared

112 Malondialdehyde content as well as protein oxidation pro

113 uced glutathione levels were higher, whereas malondialdehyde content was lower, in the renal cortex o

114 Oxidative stress, indicated by malondialdehyde content, was greater in gr3 than the WT

115 blood flows, ventilatory pressures, and lung malondialdehyde content.

116 t peroxidation in the cakes, measured as the malondialdehyde content.

117 oss, pericarp browning, membrane leakage and malondialdehyde contents.

118 escribed for the quantification of the major malondialdehyde deoxyguanosine adduct, pyrimido[1,2-alph

119 Optimization was performed on both the malondialdehyde-deoxyguanosine (M(1)dG) adduct and the O

120 The malondialdehyde-deoxyguanosine adduct, 3-(2'-deoxy-beta-

121 The major malondialdehyde-derived adduct in DNA is 3-(2'-deoxy-bet

122 e provide indirect but strong evidence for a malondialdehyde-derived cross-link requiring just one ma

123 ligands C-reactive protein, pentraxin 3, and malondialdehyde epitopes.

124 E, such as oxidized phospholipids (OxPL) and malondialdehyde epitopes.

125 munohistochemistry confirmed the presence of malondialdehyde-epitopes and iron particles.

126 ), oligonucleotide 3'-phosphoglycolates (7), malondialdehyde equivalents (8 or 9), and furfural (10).

127 Here, we show that fluorescent malondialdehyde-formaldehyde (M2FA)-lysine adducts are i

128 ing periods considered in the present study, malondialdehyde formation was affected by the NaCl level

129 he effect of an antioxidant spice mixture on malondialdehyde formation while cooking hamburger meat a

130 y-5(Z),8(E),10(E)-heptadecatrienoic acid and malondialdehyde from PGH2, but not formation of PGE2.

131 rat pups had significantly higher levels of malondialdehyde, glutathione reductase enzyme activity,

132 ation of advanced glycation end products and malondialdehyde in a dose-dependent manner.

133 The production of malondialdehyde in burgers and malondialdehyde concentra

134 gs at the end of reperfusion and assayed for malondialdehyde in combination with 4-hydroxyalkenals to

135 Reactive oxygen species and malondialdehyde in H2O2 treated CCD 841 CoN (CCD) and Ca

136 rotein), and markedly less nitrotyrosine and malondialdehyde in porphyrin-treated spinal cords relati

137 depletion of glutathione and accumulation of malondialdehyde in renal cortex.

138 re and concentrations of myeloperoxidase and malondialdehyde in the lung and gut.

139 iorated the increases in myeloperoxidase and malondialdehyde in the lung and gut.

140 al-modified proteins, protein carbonyls, and malondialdehyde) in IFM with age.

141 Malondialdehyde increased in the cortex as VC supplement

142 Malondialdehyde increased with higher roasting temperatu

143 Lipid peroxidation, as measured by malondialdehyde, increased and antioxidants (superoxide

144 ncubation of CAT with ALCAR or CoA prevented malondialdehyde-induced dysfunction.

145 Malondialdehyde interstrand cross-links in DNA show stro

146 Malondialdehyde is an endogenous product of oxidative st

147 Stabilin-1 deficiency abrogated malondialdehyde-LDL (MDA-LDL) uptake by hepatic macropha

148 mmunoglobulin G and M autoantibody titers to malondialdehyde-LDL, E06 epitope) were measured serially

149 ts induced severe tissue damage and enhanced malondialdehyde levels and senescence symptoms, but not

150 idenced by a significant increase in hepatic malondialdehyde levels and upregulation of Nrf2-regulate

151 8-Hydroxy-deoxy guanosine and malondialdehyde levels as markers of oxidative stress we

152 had no apparent effect on fatty liver tissue malondialdehyde levels augmented by Jo2.

153 The increase in renal malondialdehyde levels caused by renal I/R was also sign

154 d mucosal graft morphology, diminished graft malondialdehyde levels demonstrating substantial reducti

155 are correlated with the GSH redox state and malondialdehyde levels in heavy metal-treated algae.

156 Additionally, it lowered the malondialdehyde levels in plasma and abolished the incre

157 sser membrane damage as indicated by reduced malondialdehyde levels in transgenic leaves subjected to

158 oral neck fracture was assessed by measuring malondialdehyde levels using the thiobarbituric acid rea

159 Plasma malondialdehyde levels were also compared to assess sign

160 ere also measured: Myeloperoxidase activity, malondialdehyde levels, and plasma nitrite/nitrate.

161 ted in increased reactive oxygen species and malondialdehyde levels, disruption of mitochondrial memb

162 s without altering cerebral Bax mRNA levels, malondialdehyde levels, or caspase-3 activity.

163 ) levels and higher hepatic triglyceride and malondialdehyde levels.

164 (OSEs) reflecting oxidized phospholipids and malondialdehyde-like epitopes.

165 9 +/- 5.8 vs. 38.8 +/- 3.8; p < 0.0001), and malondialdehyde-like OSEs (93.9 +/- 7.9 vs. 54.7 +/- 3.9

166 percentage of circulating B-1 cells and anti-malondialdehyde-low-density lipoprotein IgM suggesting c

167 Synthetic ALE (malondialdehyde-lysine [MDA-Lys]) (50 micromol/l) could

168 onjugated with antibodies targeted to either malondialdehyde-lysine or oxidized phospholipid epitopes

169 olume, measurement of brain concentration of malondialdehyde (MDA) (an end-product of lipid peroxidat

170 xyguanosine (8-OHdG), protein carbonyls, and malondialdehyde (MDA) adducts of proteins, markers of ox

171 Two lipid peroxidation end products, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), show

172 Serum concentration of lipofuscine (LPS), malondialdehyde (MDA) and activity of total superoxide d

173 (SAM), and glutathione, and elevated plasma malondialdehyde (MDA) and alanine transaminase.

174 as measured by 2 lipid peroxidation markers, malondialdehyde (MDA) and F2-isoprostanes (IsoPs).

175 carbonyls resulting from lipid peroxidation (malondialdehyde (MDA) and hydroxynonenal) or carbohydrat

176 d glutathione (GSH) content, higher level of malondialdehyde (MDA) and lower levels of protein carbon

177 Malondialdehyde (MDA) and nucleobase propenals can trans

178 ns between secondary lipid oxidation product malondialdehyde (MDA) and selected beta-lactoglobulin (b

179 Serum malondialdehyde (MDA) and thioredoxin-1 (Trx1) levels we

180 s on metal ion-catalyzed oxidation of LDL to malondialdehyde (MDA) and to protein carbonyl and MetO d

181 -l-hydroxy-5,8,10-heptadecatrienoic acid and malondialdehyde (MDA) at a ratio of 1:1:1 (TXA2:heptadec

182 ameliorated the oxidative damage by reducing malondialdehyde (MDA) concentration and increasing antio

183 in hepatic pericytes, glutathione (GSH), and malondialdehyde (MDA) concentrations in liver; and serum

184 creased soluble protein content, proline and malondialdehyde (MDA) content as well as O2*(-) producti

185 s tolerance characteristics, including lower malondialdehyde (MDA) content, lower water loss rates, l

186 The soluble proteins and malondialdehyde (MDA) contents were stimulated by all te

187 We further show that malondialdehyde (MDA) epitopes, products of lipid peroxi

188 cid reactive substances (TBARS, 0.30-0.38 mg malondialdehyde (MDA) equivalents/kg mince) under low ox

189 Oxidation events such as malondialdehyde (MDA) formation may produce specific, im

190 well as levels of free radical damage marker malondialdehyde (MDA) in blood and saliva of individuals

191 contents of free amino acid, carotenoid, and malondialdehyde (MDA) in egg yolk.

192 The levels of malondialdehyde (MDA) in gamma-ECS lines were also 27.3-

193 lpha (TNF-alpha) in plasma and TNF-alpha and malondialdehyde (MDA) in lung tissues were detected.

194 ioxidant contents and increased the level of malondialdehyde (MDA) in the hippocampus and striatum of

195 utathione peroxidase (GPx) and the levels of malondialdehyde (MDA) in the oedematous paw.

196 Malondialdehyde (MDA) is a natural and widespread genoto

197 Malondialdehyde (MDA) is an endogenous genotoxic product

198 Hepatic malondialdehyde (MDA) levels (a marker of lipid peroxida

199 at test, and brain homogenates, by measuring malondialdehyde (MDA) levels as a lipoperoxidation bioma

200 Malondialdehyde (MDA) levels in the brain were measured

201 (a marker of oxidative stress) and increased malondialdehyde (MDA) levels in the hippocampus and amyg

202 Malondialdehyde (MDA) levels increased dramatically afte

203 ant effect on the fatty acid composition and malondialdehyde (MDA) levels of fresh eggs but reduced t

204 and collagen alpha1 (IV) and renal cortical malondialdehyde (MDA) levels were significantly higher i

205 n liver and cerebellum in gulo(-/-) mice and malondialdehyde (MDA) levels were significantly increase

206 elated lipid peroxidation, measured as serum malondialdehyde (MDA) levels, correlates with delayed gr

207 panied by a concomitant decrease in cellular malondialdehyde (MDA) levels.

208 of oxidative stress and can be evaluated via malondialdehyde (MDA) levels.

209 the evaluation of methemoglobin (MetHb) and malondialdehyde (MDA) levels.

210 Measurement of malondialdehyde (MDA) showed that NACA reduced glutamate

211 The increased production of malondialdehyde (MDA) suggests that Ga stress could caus

212 Organ malondialdehyde (MDA) was determined on day 5 as an inde

213 Malondialdehyde (MDA) was measured as a marker of oxidat

214 Circulating inflammatory markers and malondialdehyde (MDA) were measured before and after tre

215 d the levels of oxidative damage biomarkers, malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), aconita

216 Malondialdehyde (MDA), a major product of lipid peroxida

217 Urinary malondialdehyde (MDA), a marker of lipid peroxidation, w

218 wn to arise in vitro in reactions of dG with malondialdehyde (MDA), a product of both lipid peroxidat

219 soluble antioxidants, the cellular amount of malondialdehyde (MDA), a product of lipid peroxidation,

220 es exposed during programmed cell death, and malondialdehyde (MDA), a reactive aldehyde degradation p

221 rates lipid fragmentation products including malondialdehyde (MDA), an archetypal marker of PUFA oxid

222 At both low and high AA intakes, hepatic malondialdehyde (MDA), an indicator of oxidative stress,

223 Total antioxidant capacity, plasma levels of malondialdehyde (MDA), and activities of glutathione per

224 ), blood levels of C-reactive protein (CRP), malondialdehyde (MDA), and CD11b/c positive cell ratio w

225 is study is to determine the serum levels of malondialdehyde (MDA), as a lipid peroxidation marker, a

226 quantification of conjugated dienes (CD) and malondialdehyde (MDA), but also by assessment of tocophe

227 DEN administration increased the levels of malondialdehyde (MDA), DNA fragmentation, caspase-3 and

228 length between functional groups were used: malondialdehyde (MDA), glutaraldehyde and hexamethylene

229 derived aldehydes, 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), glyoxal (GLY), atheronal-A (KA),

230 Biomarkers of oxidation, such as malondialdehyde (MDA), may represent independent indicat

231 Renal function, histopathology, malondialdehyde (MDA), myeloperoxidase levels, and antio

232 Malondialdehyde (MDA), nitric oxide (NO), superoxide dis

233 urobehavioral scores and infarction volumes, malondialdehyde (MDA), reactive oxygen species (ROS), an

234 num and ileum were analyzed by histology and malondialdehyde (MDA), respectively.

235 centrations of 4-hydroxyalkenals (4-HNE) and malondialdehyde (MDA), was reduced significantly by V-PY

236 In this study, levels of malondialdehyde (MDA), which is a significant product of

237 6, lipoprotein(a) [Lp(a)], autoantibodies to malondialdehyde (MDA)-LDL and copper-oxidized LDL (Cu-Ox

238 ane generation and autoantibody formation to malondialdehyde (MDA)-LDL, an epitope of LDL formed as a

239 , immunoglobulin (Ig)G/IgM autoantibodies to malondialdehyde (MDA)-LDL, and apolipoprotein B (apoB)-i

240 munoglobulin (Ig)G and IgM autoantibodies to malondialdehyde (MDA)-low-density lipoprotein (LDL) and

241 ine monoclonal IgG antibody MDA2 targeted to malondialdehyde (MDA)-lysine epitopes or the human singl

242 rphology and contractility, Ca(2+) handling, malondialdehyde (MDA)-modified proteins, and ROS levels

243 w-density lipoprotein (LDL) cholesterol, and malondialdehyde (MDA).

244 cysteine 328 (C328) by the oxidative adduct malondialdehyde (MDA).

245 oduct of the reaction of deoxyguanosine with malondialdehyde (MDA).

246 to proteins where lysines have reacted with malondialdehyde (MDA).

247 to lipid peroxidation of liver tissue with a malondialdehyde (MDA)/free fatty acids (FFA) ratio of 0.

248 O, indicator of neutrophil accumulation) and malondialdehyde (MDA, indicator of lipid peroxidation),

249 used for the analysis of lipid peroxidation (malondialdehyde [MDA]) and antioxidant enzymes (catalase

250 in B) and more oxidized (5.7 versus 1.5 nmol malondialdehyde/mg lipoprotein).

251 ious oxidation-specific neoepitopes, such as malondialdehyde-modified (MDA-modified) LDL (MDA-LDL) or

252 ion end products-modified LDL (AGE-LDL), and malondialdehyde-modified LDL (MDA-LDL) in IC and determi

253 noglobulin (Ig) G1, IgG2b, and IgG2c against malondialdehyde-modified LDL (MDA-LDL), presumably as a

254 The results demonstrate that injection of malondialdehyde-modified LDL promotes a Th2 response tha

255 ed lipoproteins, including autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LD

256 m of recombinant mouse CD16 (sCD16) bound to malondialdehyde-modified low-density lipoprotein (MDALDL

257 hose on oxidized low-density lipoprotein and malondialdehyde-modified low-density lipoprotein.

258 bulin (Ig)-G (IgG) and IgM autoantibodies to malondialdehyde-modified, low-density lipoprotein (MDA-L

259 dehyde-derived cross-link requiring just one malondialdehyde molecule to link arginine and lysine, gi

260 injury, as evidenced by decreased levels of malondialdehyde, myeloperoxidase activity, and tumor nec

261 Moreover, SRT1720 decreased the levels of malondialdehyde, nitrotyrosine, and inducible nitric oxi

262 Although collagen is readily cross-linked by malondialdehyde, none of these particular products could

263 milk produced significantly lower amounts of malondialdehyde of 0.46+/-0.04mugMDA/ml after 3days at 3

264 of CAT with the lipid peroxidation products malondialdehyde or 4-hydroxy-nonenal caused a decrease i

265 10(3H)-on e], formed in DNA upon exposure to malondialdehyde or base propenals, was incorporated into

266 ajor reaction product of deoxyguanosine with malondialdehyde or base propenals.

267 DL oxidizability, urinary F(2)-isoprostanes, malondialdehyde, or protein carbonyls in native plasma).

268 anosine with the lipid peroxidation product, malondialdehyde, or the DNA peroxidation product, base p

269 tments affected fillet lipid oxidation (free malondialdehyde), pigmentation and flavour volatile comp

270 by a 4.5-fold higher concentration of plasma malondialdehyde (PkB luciferase reporter construct trans

271 se in lipid peroxidation, as assessed by LDL-malondialdehyde plasma concentration, was found in HC bu

272 AA repletion, led to oxidative stress (using malondialdehyde production as an index) and to major inc

273 on of ApoB, conjugated diene production, and malondialdehyde production through Cu(2+)-mediated oxida

274 athione-s-transferase and catalase activity, malondialdehyde production, and induction of apoptosis.

275 avengers, Fe(2+) chelators and inhibitors of malondialdehyde production, while the essential oil was

276 g; and (4) interleukin-1beta, nitrotyrosine, malondialdehyde, protein carbonyl, and Fas/Fas ligand le

277 ock-out mice also showed increased levels of malondialdehyde, protein carbonyls, protein methionine s

278 increased levels of 4-hydroxy-2-nonenal- and malondialdehyde-protein adducts.

279 Base propenals and malondialdehyde react with DNA to form adducts, includin

280 ota rod tests), oxidative stress parameters (malondialdehyde, reduced glutathione, and superoxide dis

281 and oxidative stress: C-reactive protein and malondialdehyde, respectively.

282 ts improved the redox status by reducing the malondialdehyde serum levels and protein oxidative damag

283 hat the trimethylene tether and probably the malondialdehyde tether, as well, could be accommodated w

284 hamburger meat can promote the formation of malondialdehyde that can be absorbed after ingestion.

285 Plasma antioxidants, protein carbonyls, malondialdehyde, total antioxidant performance, LDL oxid

286 ively, and urinary lipid peroxidation marker malondialdehyde was decreased by 32 +/- 21% compared to

287 Lung malondialdehyde was determined.

288 Lung malondialdehyde was significantly less in LH (LH, 0.33 +

289 Plasma malondialdehyde was significantly reduced with allopurin

290 Myeloperoxidase and malondialdehyde were also measured to study neutrophil a

291 F(2)-isoprostanes and malondialdehyde were lower in the GSTM1-0 and GSTT1-0 gr

292 -7,8-dihydro-2'-deoxyguanosine (8-oxodG) and malondialdehyde were measured in urine samples collected

293 tissue concentrations of myeloperoxidase and malondialdehyde were measured.

294 rbic acid and markers of lipid peroxidation (malondialdehyde) were monitored.

295 lglucosinolate, 5-hydroxymethylfurfural, and malondialdehyde) were not detected in any tissue sample

296 ate dehydrogenase by 4-hydroxy-2-nonenal and malondialdehyde when co-incubated with NADP(+), reinforc

297 significantly decrease the concentration of malondialdehyde, which suggests potential health benefit

298 The level of malondialdehyde, which was significantly higher (P = 0.0

299 kely produced by endogenous formaldehyde and malondialdehyde with lysine.

300 n of peroxidation products, base propenal or malondialdehyde, with deoxyguanosine residues in DNA.